Underactive Bladder and Detrusor Activity in Aging (R01, R03, R21 Clinical Trial Optional)

Funding Agency:
National Institutes of Health
This Funding Opportunity Announcement (FOA) invites applications that propose basic, clinical, or translational research on underactive bladder (UAB) and detrusor underactivity (DU) and its consequences in aging and in older persons. Applications should focus on the 1) biology, etiology and pathophysiology of DU or UAB in animal models and/or older adults; 2) translation of basic/clinical research into clinical practice and health decision making; 3) diagnosis, prevention, management and clinical outcomes of UAB in older adults; and/or 4) epidemiology and risk factors for the development of DU/UAB with advancing age. Research supported by this initiative should enhance knowledge of DU/UAB and its consequences in older adults and provide evidence-based guidance in the diagnosis, evaluation, and treatment of DU/UAB in older persons.
 
Although this funding opportunity uses the R01 grant mechanism, it runs in parallel with two program announcements of identical scientific scope: PA-18-571, for the R03 Small Grant Program, and  PA-18-572, for R21 Exploratory/Developmental Grants.
 
Deadlines:
  • R01 Due Dates: Feb. 5, Jun. 5, Oct. 5
  • R03 and R21 Due Dates: Feb. 16, Jun. 16, Oct. 16
  • AIDS Due Dates: Jan. 7, May 7, Sep. 7

PA-18-570 Expiration Date May 8, 2021

Eligibility

Faculty

Category

Interdisciplinary
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

February 5, 2021